|
|
|
| TRIPTERINE | ||
|
PRODUCT IDENTIFICATION |
||
| CAS NO. | 34157-83-0 |
|
| EINECS NO. | ||
| FORMULA | C29H38O4 | |
| MOL WT. | 450.61 | |
|
H.S. CODE |
||
|
TOXICITY |
||
| DERIVATION |
|
|
| SYNONYMS | Celastrol; | |
| (2R,4aS,6aS,6aR,14bR)-10-hydroxy-2,4a,6a,6a,9,14a-hexamethyl-11-oxo-1,3,4,5,6, 13,14,14b- octahydropicene-2-carboxylic acid; (20alpha)-3-Hydroxy-2-oxo- D:A-Friedo-24- noroleana- 1(10),3,5,7- tetraen-29-oic acid; 10-Hydroxy-2,4a,6a,9,12b,14a-hexamethyl-11-oxo-1,2,3,4,4a, 5,6,6a,11,12b,13,14,14a,14b- tetradecahydropicene-2-carboxylic acid; | ||
|
CLASSIFICATION |
||
|
PHYSICAL AND CHEMICAL PROPERTIES |
||
| PHYSICAL STATE |
red crystalline powder | |
| MELTING POINT |
| |
| BOILING POINT | ||
| SPECIFIC GRAVITY | ||
| SOLUBILITY IN WATER |
Insoluble | |
| pH | ||
| VAPOR DENSITY | ||
|
AUTOIGNITION |
| |
|
NFPA RATINGS |
Health Hazard: 2 Fire: 0 Reactivity Hazard:0 | |
|
REFRACTIVE INDEX |
| |
| FLASH POINT |
| |
| STABILITY | Stable under ordinary conditions. | |
|
GENERAL DESCRIPTION & EXTERNAL LINKS |
||
|
Celastrol has been effectively used in the treatment of autoimmune diseases, asthma, chronic inflammation, and neurodegenerative disease. Under in vitro conditions, Celastrol was found to inhibit cancer cell proliferation and induce leukemic cell death; however, the molecular mechanism involved still remains unclear. (http://cancerres.aacrjournals.org/) Tripterine (celastrol) is a pentacyclic triterpenoid compound isolated from the Chinese Tripterygium wilfordii Hook. It has an activity of immunosuppressive and anti-inflammatory. Triterpenes antioxidants are not common, but tripterine's antioxidant potency is equivalent to about 15 times that of alpha-tocopherol. |
||
| SALES SPECIFICATION | ||
|
APPEARANCE |
red crystalline powder |
|
| PURITY | 98.0% min | |
| WATER | 2.0% min | |
| TRANSPORTATION | ||
| PACKING | III | |
| HAZARD CLASS | 6.1 | |
| UN NO. | 2811 | |
| OTHER INFORMATION | ||
| Hazard Symbols: T, Risk Phrases:25 , Safety Phrases: 45 | ||
|
PRICES |
||
|
|
|